Evron, E <br/><br/>
Loss of cyclin D2 expression in the majority of breast cancers is associated with promoter hypermethylation.  [electronic resource] 

 -  Cancer research  Mar 2001 
 - 2782-7 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S. 
<br/><br/><label>ISSN: </label>0008-5472 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Blotting, Western<br/>Breast--cytology<br/>Breast Neoplasms--genetics<br/>Carcinoma in Situ--genetics<br/>Carcinoma, Ductal, Breast--genetics<br/>CpG Islands<br/>Cyclin D2<br/>Cyclins--biosynthesis<br/>DNA Methylation<br/>Female<br/>Gene Expression Regulation, Neoplastic<br/>Gene Silencing<br/>Humans<br/>Promoter Regions, Genetic<br/>RNA, Messenger--biosynthesis<br/>Reverse Transcriptase Polymerase Chain Reaction